Truman Medical Center goes live with the DxH 900 hematology analyzer

Check out Truman Medical Center's experience with the DxH 900 hematology analyzer and hear how they feel about the clinical and workflow benefits of the analyzer.
The DxH 900 hematology analyzer enables clinical laboratories like Truman Medical Center to perform complete blood count and white blood cell differential tests. Demonstrating an industry-leading 93% first-pass yield, the DxH 900 reduces the number of manual slide reviews, helping to generate reportable results as quickly as possible. In addition, the DxH 900 features the Early Sepsis Indicator, the only CE marked and FDA-cleared hematologic biomarker that aids the diagnosis of sepsis in adult patients. #Hematology #Sepsis